NO20061576L - Fremgangsmater for fremstilling av rekombinante proteiner - Google Patents

Fremgangsmater for fremstilling av rekombinante proteiner

Info

Publication number
NO20061576L
NO20061576L NO20061576A NO20061576A NO20061576L NO 20061576 L NO20061576 L NO 20061576L NO 20061576 A NO20061576 A NO 20061576A NO 20061576 A NO20061576 A NO 20061576A NO 20061576 L NO20061576 L NO 20061576L
Authority
NO
Norway
Prior art keywords
recombinant protein
growth rate
coli host
methods
recombinant proteins
Prior art date
Application number
NO20061576A
Other languages
English (en)
Norwegian (no)
Inventor
Mukesh Sehdev
Dominic Gambier Reeks
David John Glover
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29226759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20061576(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of NO20061576L publication Critical patent/NO20061576L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO20061576A 2003-09-09 2006-04-07 Fremgangsmater for fremstilling av rekombinante proteiner NO20061576L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0321100.0A GB0321100D0 (en) 2003-09-09 2003-09-09 Biological products
PCT/GB2004/003747 WO2005024000A1 (en) 2003-09-09 2004-09-02 Methods for producing recombinant proteins

Publications (1)

Publication Number Publication Date
NO20061576L true NO20061576L (no) 2006-04-07

Family

ID=29226759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20061576A NO20061576L (no) 2003-09-09 2006-04-07 Fremgangsmater for fremstilling av rekombinante proteiner

Country Status (20)

Country Link
US (2) USRE44512E1 (de)
EP (1) EP1664278B1 (de)
JP (1) JP4568722B2 (de)
KR (1) KR20060125704A (de)
CN (1) CN1849389B (de)
AT (1) ATE454444T1 (de)
AU (1) AU2004270929B2 (de)
BR (1) BRPI0413813A (de)
CA (1) CA2536099C (de)
DE (1) DE602004025011D1 (de)
EA (1) EA200600554A1 (de)
ES (1) ES2339352T3 (de)
GB (1) GB0321100D0 (de)
IL (1) IL173474A0 (de)
MX (1) MXPA06002589A (de)
NO (1) NO20061576L (de)
PL (1) PL1664278T3 (de)
SG (1) SG145696A1 (de)
WO (1) WO2005024000A1 (de)
ZA (1) ZA200601177B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE515566T1 (de) * 2005-05-26 2011-07-15 Cytos Biotechnology Ag Skalierbares fermentationsverfahren
CN104928336B (zh) 2009-10-26 2020-05-08 弗·哈夫曼-拉罗切有限公司 用于生产糖基化免疫球蛋白的方法
JP6362543B2 (ja) 2012-02-23 2018-07-25 ジュノ セラピューティクス ゲーエムベーハー 細胞および他の複雑な生物学的材料のクロマトグラフィーによる単離
CN108410788A (zh) * 2012-03-12 2018-08-17 韩美科学株式会社 高密度培养大肠杆菌细胞的方法
HK1249847A1 (zh) 2015-03-09 2018-11-16 Intekrin Therapeutics, Inc. 用於治疗非酒精性脂肪肝疾病和/或脂肪营养不良的方法
CN108474791B (zh) 2015-10-22 2022-07-08 朱诺治疗学有限公司 培养细胞的方法及用于该方法的试剂盒和设备
HK1258932A1 (zh) 2015-10-22 2019-11-22 Juno Therapeutics Gmbh 用於转导的方法、反应剂盒、反应剂和设备
CN109312299A (zh) 2016-03-29 2019-02-05 格尔托公司 蛋白质在具有0.5:1至10:1的周质体积与细胞质体积比的革兰氏阴性菌中的表达
KR20200036808A (ko) 2017-04-03 2020-04-07 코히러스 바이오사이언시스, 인크. 진행성 핵상 마비 치료를 위한 PPARγ 작용제
MA49288A (fr) 2017-04-27 2020-03-04 Juno Therapeutics Gmbh Reactifs particulaires oligomères et leurs méthodes d'utilisation
US11180541B2 (en) 2017-09-28 2021-11-23 Geltor, Inc. Recombinant collagen and elastin molecules and uses thereof
EP3874024A1 (de) 2018-10-31 2021-09-08 Juno Therapeutics GmbH Verfahren zur selektion und stimulation von zellen und vorrichtung dafür
US20200207812A1 (en) 2018-12-07 2020-07-02 Coherus Biosciences, Inc. Methods for producing recombinant proteins
TW202104254A (zh) 2019-04-12 2021-02-01 美商格爾托公司 重組彈性蛋白及其生產
WO2021072182A1 (en) 2019-10-11 2021-04-15 Coherus Biosciences, Inc. Methods for producing ranibizumab
US20240092883A1 (en) 2019-10-11 2024-03-21 Coherus Biosciences, Inc. Methods of purifying ranibizumab or a ranibizumab variant
CN113355264B (zh) * 2021-06-28 2022-03-08 山东智汇达海洋生物科技有限公司 一株产甘油的嗜高温菌及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0335567A3 (de) 1988-03-30 1990-11-14 Biogen, Inc. Kontrollierte Freisetzung periplasmatischer Proteine in das Medium
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
GB8928874D0 (en) 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
CA2090126C (en) 1990-08-02 2002-10-22 John W. Schrader Methods for the production of proteins with a desired function
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
CA2426100A1 (en) * 2000-11-03 2002-05-23 Genentech, Inc. Metabolic rate shifts in fermentations expressing recombinant proteins
ATE353969T1 (de) 2003-08-13 2007-03-15 Sandoz Ag Expressionsvektoren, transformierte wirtszellen und fermentationsverfahren zur herstellung rekombinanter polypeptide

Also Published As

Publication number Publication date
EP1664278A1 (de) 2006-06-07
AU2004270929B2 (en) 2010-01-21
JP2007504815A (ja) 2007-03-08
EA200600554A1 (ru) 2006-08-25
WO2005024000A1 (en) 2005-03-17
DE602004025011D1 (de) 2010-02-25
SG145696A1 (en) 2008-09-29
CA2536099C (en) 2015-11-17
EP1664278B1 (de) 2010-01-06
AU2004270929A1 (en) 2005-03-17
CN1849389B (zh) 2012-05-23
BRPI0413813A (pt) 2006-10-17
ES2339352T3 (es) 2010-05-19
KR20060125704A (ko) 2006-12-06
GB0321100D0 (en) 2003-10-08
ATE454444T1 (de) 2010-01-15
IL173474A0 (en) 2006-06-11
USRE44512E1 (en) 2013-10-01
US7754447B2 (en) 2010-07-13
PL1664278T3 (pl) 2010-06-30
CN1849389A (zh) 2006-10-18
MXPA06002589A (es) 2006-06-05
ZA200601177B (en) 2007-04-25
CA2536099A1 (en) 2005-03-17
JP4568722B2 (ja) 2010-10-27
US20080044817A1 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
ATE454444T1 (de) Verfahren zur herstellung rekombinanter proteine
Wells et al. Cellular engineering for therapeutic protein production: product quality, host modification, and process improvement
US12098373B2 (en) Bacillus subtilis efficiently-induced expression system based on artificial series promoter
SG149003A1 (en) Gene expression technique
JP5354559B2 (ja) 高効率分泌シグナルペプチド及びそれらを利用したタンパク質発現系
IL155482A (en) Method for increasing product yield of a mammalian polypeptide produced by recombinant bacterial host cells
WO2002099067A3 (en) Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
JP2005529610A5 (de)
CN105358706A (zh) 用于蛋白质表达的酵母启动子
RU2016152693A (ru) Способ культивирования клеток для получения белка
DK1897939T3 (da) Mikroorganismestamme til produktion af rekombinante proteiner
Liu et al. Sensor kinase KinB and its pathway‐associated key factors sense the signal of nutrition starvation in sporulation of Bacillus subtilis
CN120796373B (zh) 小麦转录因子TaWRKY22及其编码基因在调控植物条锈病抗性中的应用
Acosta-Rivero et al. Improvement of human interferon HUIFNα2 and HCV core protein expression levels in Escherichia coli but not of HUIFNα8 by using the tRNAAGA/AGG
CN106434722B (zh) 一种优化的pBBR1MCS系列载体及其应用
CN118406709A (zh) 一种分泌表达的枯草芽孢杆菌及其应用
JP2021101733A (ja) 新規宿主細胞及びそれを用いた目的タンパク質の製造方法
US11365419B2 (en) Host cell and method for producing target protein using same
Lübke et al. Analysis and optimization of recombinant protein production in Escherichia coli using the inducible pho A promoter of the E. coli alkaline phosphatase
JP2018518985A5 (de)
GB0228465D0 (en) A method of treating disease
RU2008112882A (ru) Новая система селекции
Edwards et al. Aspergillus nidulans Transcription Factor BrlA is Utilized in a Conidiation-Independent Response to Cell-Wall Stress
CN103642838B (zh) 一种人类及哺乳动物细胞表达载体及其应用
Serio et al. Expression of yeast mitochondrial aconitase in Bacillus subtilis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application